Global Nontuberculous Mycobacterium Treatment Market Growth (Status and Outlook) 2023-2029
LPI (LP Information)' newest research report, the “Nontuberculous Mycobacterium Treatment Industry Forecast” looks at past sales and reviews total world Nontuberculous Mycobacterium Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Nontuberculous Mycobacterium Treatment sales for 2023 through 2029. With Nontuberculous Mycobacterium Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nontuberculous Mycobacterium Treatment industry.
This Insight Report provides a comprehensive analysis of the global Nontuberculous Mycobacterium Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nontuberculous Mycobacterium Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nontuberculous Mycobacterium Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nontuberculous Mycobacterium Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nontuberculous Mycobacterium Treatment.
The global Nontuberculous Mycobacterium Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nontuberculous Mycobacterium Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nontuberculous Mycobacterium Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nontuberculous Mycobacterium Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nontuberculous Mycobacterium Treatment players cover Insmed Incorporated, RedHill Biopharma, Novoteris, Savara and Beyond Air, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nontuberculous Mycobacterium Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Azithromycin
Rifampin
Rifabutin
Ethambuto
Segmentation by application
Hospitals Pharmacies
Private clinics
Drug Stores and Retail Pharmacy
E-commerce
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Insmed Incorporated
RedHill Biopharma
Novoteris
Savara
Beyond Air
Please note: The report will take approximately 2 business days to prepare and deliver.
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Nontuberculous Mycobacterium Treatment Market Size 2018-2029
- 2.1.2 Nontuberculous Mycobacterium Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Nontuberculous Mycobacterium Treatment Segment by Type
- 2.2.1 Azithromycin
- 2.2.2 Rifampin
- 2.2.3 Rifabutin
- 2.2.4 Ethambuto
- 2.3 Nontuberculous Mycobacterium Treatment Market Size by Type
- 2.3.1 Nontuberculous Mycobacterium Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Nontuberculous Mycobacterium Treatment Market Size Market Share by Type (2018-2023)
- 2.4 Nontuberculous Mycobacterium Treatment Segment by Application
- 2.4.1 Hospitals Pharmacies
- 2.4.2 Private clinics
- 2.4.3 Drug Stores and Retail Pharmacy
- 2.4.4 E-commerce
- 2.5 Nontuberculous Mycobacterium Treatment Market Size by Application
- 2.5.1 Nontuberculous Mycobacterium Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Nontuberculous Mycobacterium Treatment Market Size Market Share by Application (2018-2023)
- 3 Nontuberculous Mycobacterium Treatment Market Size by Player
- 3.1 Nontuberculous Mycobacterium Treatment Market Size Market Share by Players
- 3.1.1 Global Nontuberculous Mycobacterium Treatment Revenue by Players (2018-2023)
- 3.1.2 Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Players (2018-2023)
- 3.2 Global Nontuberculous Mycobacterium Treatment Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Nontuberculous Mycobacterium Treatment by Regions
- 4.1 Nontuberculous Mycobacterium Treatment Market Size by Regions (2018-2023)
- 4.2 Americas Nontuberculous Mycobacterium Treatment Market Size Growth (2018-2023)
- 4.3 APAC Nontuberculous Mycobacterium Treatment Market Size Growth (2018-2023)
- 4.4 Europe Nontuberculous Mycobacterium Treatment Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size Growth (2018-2023)
- 5 Americas
- 5.1 Americas Nontuberculous Mycobacterium Treatment Market Size by Country (2018-2023)
- 5.2 Americas Nontuberculous Mycobacterium Treatment Market Size by Type (2018-2023)
- 5.3 Americas Nontuberculous Mycobacterium Treatment Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Nontuberculous Mycobacterium Treatment Market Size by Region (2018-2023)
- 6.2 APAC Nontuberculous Mycobacterium Treatment Market Size by Type (2018-2023)
- 6.3 APAC Nontuberculous Mycobacterium Treatment Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Nontuberculous Mycobacterium Treatment by Country (2018-2023)
- 7.2 Europe Nontuberculous Mycobacterium Treatment Market Size by Type (2018-2023)
- 7.3 Europe Nontuberculous Mycobacterium Treatment Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Nontuberculous Mycobacterium Treatment by Region (2018-2023)
- 8.2 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Nontuberculous Mycobacterium Treatment Market Forecast
- 10.1 Global Nontuberculous Mycobacterium Treatment Forecast by Regions (2024-2029)
- 10.1.1 Global Nontuberculous Mycobacterium Treatment Forecast by Regions (2024-2029)
- 10.1.2 Americas Nontuberculous Mycobacterium Treatment Forecast
- 10.1.3 APAC Nontuberculous Mycobacterium Treatment Forecast
- 10.1.4 Europe Nontuberculous Mycobacterium Treatment Forecast
- 10.1.5 Middle East & Africa Nontuberculous Mycobacterium Treatment Forecast
- 10.2 Americas Nontuberculous Mycobacterium Treatment Forecast by Country (2024-2029)
- 10.2.1 United States Nontuberculous Mycobacterium Treatment Market Forecast
- 10.2.2 Canada Nontuberculous Mycobacterium Treatment Market Forecast
- 10.2.3 Mexico Nontuberculous Mycobacterium Treatment Market Forecast
- 10.2.4 Brazil Nontuberculous Mycobacterium Treatment Market Forecast
- 10.3 APAC Nontuberculous Mycobacterium Treatment Forecast by Region (2024-2029)
- 10.3.1 China Nontuberculous Mycobacterium Treatment Market Forecast
- 10.3.2 Japan Nontuberculous Mycobacterium Treatment Market Forecast
- 10.3.3 Korea Nontuberculous Mycobacterium Treatment Market Forecast
- 10.3.4 Southeast Asia Nontuberculous Mycobacterium Treatment Market Forecast
- 10.3.5 India Nontuberculous Mycobacterium Treatment Market Forecast
- 10.3.6 Australia Nontuberculous Mycobacterium Treatment Market Forecast
- 10.4 Europe Nontuberculous Mycobacterium Treatment Forecast by Country (2024-2029)
- 10.4.1 Germany Nontuberculous Mycobacterium Treatment Market Forecast
- 10.4.2 France Nontuberculous Mycobacterium Treatment Market Forecast
- 10.4.3 UK Nontuberculous Mycobacterium Treatment Market Forecast
- 10.4.4 Italy Nontuberculous Mycobacterium Treatment Market Forecast
- 10.4.5 Russia Nontuberculous Mycobacterium Treatment Market Forecast
- 10.5 Middle East & Africa Nontuberculous Mycobacterium Treatment Forecast by Region (2024-2029)
- 10.5.1 Egypt Nontuberculous Mycobacterium Treatment Market Forecast
- 10.5.2 South Africa Nontuberculous Mycobacterium Treatment Market Forecast
- 10.5.3 Israel Nontuberculous Mycobacterium Treatment Market Forecast
- 10.5.4 Turkey Nontuberculous Mycobacterium Treatment Market Forecast
- 10.5.5 GCC Countries Nontuberculous Mycobacterium Treatment Market Forecast
- 10.6 Global Nontuberculous Mycobacterium Treatment Forecast by Type (2024-2029)
- 10.7 Global Nontuberculous Mycobacterium Treatment Forecast by Application (2024-2029)
- 11 Key Players Analysis
- 11.1 Insmed Incorporated
- 11.1.1 Insmed Incorporated Company Information
- 11.1.2 Insmed Incorporated Nontuberculous Mycobacterium Treatment Product Offered
- 11.1.3 Insmed Incorporated Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 Insmed Incorporated Main Business Overview
- 11.1.5 Insmed Incorporated Latest Developments
- 11.2 RedHill Biopharma
- 11.2.1 RedHill Biopharma Company Information
- 11.2.2 RedHill Biopharma Nontuberculous Mycobacterium Treatment Product Offered
- 11.2.3 RedHill Biopharma Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 RedHill Biopharma Main Business Overview
- 11.2.5 RedHill Biopharma Latest Developments
- 11.3 Novoteris
- 11.3.1 Novoteris Company Information
- 11.3.2 Novoteris Nontuberculous Mycobacterium Treatment Product Offered
- 11.3.3 Novoteris Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 Novoteris Main Business Overview
- 11.3.5 Novoteris Latest Developments
- 11.4 Savara
- 11.4.1 Savara Company Information
- 11.4.2 Savara Nontuberculous Mycobacterium Treatment Product Offered
- 11.4.3 Savara Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 Savara Main Business Overview
- 11.4.5 Savara Latest Developments
- 11.5 Beyond Air
- 11.5.1 Beyond Air Company Information
- 11.5.2 Beyond Air Nontuberculous Mycobacterium Treatment Product Offered
- 11.5.3 Beyond Air Nontuberculous Mycobacterium Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 Beyond Air Main Business Overview
- 11.5.5 Beyond Air Latest Developments
- 12 Research Findings and Conclusion
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook